Haluk Eraksoy
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 11
- Co-authors
- Arif Atahan ÇağataySelim BadurSemra ÇalanguLaurent PoirelAmélie CarrërHalit ÖzsütPatrice NordmannSerkan Öncü
- Journals
- Future Microbiology (2 papers)Medical Microbiology and Immunology (2 papers)BMC Infectious Diseases (2 papers)Clinical Microbiology and Infection (2 papers)Journal of the International AIDS Society (2 papers)
- Partner nations
- TürkiyeGermanyUnited States
In The Last Decade
Haluk Eraksoy
73 papers receiving 971 citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 239
- Applied Microbiology and Biotechnology 66
- Endocrinology 110
- Critical Care and Intensive Care Medicine 94
- Transplantation 44
Countries citing papers authored by Haluk Eraksoy
This map shows the geographic impact of Haluk Eraksoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haluk Eraksoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haluk Eraksoy more than expected).
Fields of papers citing papers by Haluk Eraksoy
This network shows the impact of papers produced by Haluk Eraksoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haluk Eraksoy. The network helps show where Haluk Eraksoy may publish in the future.
Co-authors
The 25 scholars most cited alongside Haluk Eraksoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 14 | |
| 12 | 2019 | 1 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 11 | |
| 15 | [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study]. | 2011 | 5 |
| 16 | 2008 | 9 | |
| 17 | 2007 | 32 | |
| 18 | 2007 | 16 | |
| 19 | 2004 | 37 | |
| 20 | 1999 | 48 |
About Haluk Eraksoy
Haluk Eraksoy is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Virology, Infectious Diseases and Clinical Biochemistry, having authored 78 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), HIV Research and Treatment (9 papers), Bacterial Identification and Susceptibility Testing (8 papers), HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (7 papers), Pneumonia and Respiratory Infections (7 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Molecular Medicine (239 citations), Applied Microbiology and Biotechnology (66 citations), Endocrinology (110 citations), Critical Care and Intensive Care Medicine (94 citations) and Transplantation (44 citations). Haluk Eraksoy has collaborated with scholars based in Türkiye, Germany and United States. Frequent co-authors include Arif Atahan Çağatay, Selim Badur, Semra Çalangu, Laurent Poirel, Amélie Carrër, Halit Özsüt, Patrice Nordmann, Serkan Öncü, Nahit Çakar and Atahan Çağatay. Their work appears in journals such as Future Microbiology, Medical Microbiology and Immunology, BMC Infectious Diseases, Clinical Microbiology and Infection and Journal of the International AIDS Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.